SOURCE: American CryoStem Corporation

American CryoStem Corporation

March 24, 2011 16:01 ET

American CryoStem Announces Asset Sale

RED BANK, NJ--(Marketwire - March 24, 2011) -  American CryoStem Corporation (PINKSHEETS: AMCY) announced today that it has entered into an agreement to sell all of its assets to R&A Productions, Inc. in exchange for a controlling interest in R&A Productions, Inc. The transaction is subject, among other conditions, to the completion of due diligence by both companies.

About American CryoStem: American CryoStem Corporation (PINKSHEETS: AMCY) has developed and markets, a proprietary core processing platform for Adipose (fat) Derived Adult Stem Cells. The Company is in the business of collecting, processing, and long term storage of adult stem cells, allowing healthy individuals to privately preserve their stem cells for future use in cell therapy at an affordable price. Adult Stem Cells are currently being used in the emerging field of regenerative medicine to potentially heal over an estimated 100+ diseases and chronic conditions. Our proprietary platform provides a streamlined and affordable method to process and cryopreserve Adipose Tissue and Adipose Derived Stem Cells (ADSC) for autologous (self) use in humans.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the Company is detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact Information

  • For More Information, contact:

    Investor Relations
    American CryoStem Corporation
    188 East Bergen Place, Suite 204
    Red Bank, NJ 07701
    Phone: 732-747-1007
    Fax: 732-747-7782
    Email Contact